ATA185885A - Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols - Google Patents
Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazolsInfo
- Publication number
- ATA185885A ATA185885A AT0185885A AT185885A ATA185885A AT A185885 A ATA185885 A AT A185885A AT 0185885 A AT0185885 A AT 0185885A AT 185885 A AT185885 A AT 185885A AT A185885 A ATA185885 A AT A185885A
- Authority
- AT
- Austria
- Prior art keywords
- guanidinothiazol
- methylth
- thiadiazol
- ethylamino
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0179289A ATA179289A (de) | 1984-06-22 | 1989-07-25 | Verfahren zur herstellung des neuen n-(2-((2guanidinothiazol-4-yl)methyl-thio)ethyl)ethandiimidamids |
AT0260889A ATA260889A (de) | 1984-06-22 | 1989-11-15 | Verfahren zur herstellung des neuen n-(2-( (2-guanidinothiazol-4-yl)methylthio)-ethyl)- ethandiimidamids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/623,588 US4644006A (en) | 1984-06-22 | 1984-06-22 | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA185885A true ATA185885A (de) | 1989-12-15 |
AT390790B AT390790B (de) | 1990-06-25 |
Family
ID=24498651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0185885A AT390790B (de) | 1984-06-22 | 1985-06-21 | Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols |
Country Status (33)
Country | Link |
---|---|
US (1) | US4644006A (de) |
JP (2) | JPS6118775A (de) |
KR (1) | KR900004321B1 (de) |
AR (1) | AR240935A1 (de) |
AT (1) | AT390790B (de) |
AU (2) | AU580605B2 (de) |
BE (1) | BE902724A (de) |
CA (2) | CA1267412A (de) |
CH (1) | CH665210A5 (de) |
CS (1) | CS257276B2 (de) |
DD (1) | DD240889A5 (de) |
DE (1) | DE3522101A1 (de) |
DK (1) | DK282885A (de) |
ES (2) | ES8702902A1 (de) |
FI (1) | FI852405L (de) |
FR (1) | FR2566406B1 (de) |
GB (2) | GB2161157B (de) |
GR (1) | GR851514B (de) |
HU (1) | HU193992B (de) |
IE (2) | IE57937B1 (de) |
IL (1) | IL75567A0 (de) |
IT (1) | IT1190372B (de) |
LU (1) | LU85969A1 (de) |
NL (1) | NL8501766A (de) |
NO (1) | NO161856C (de) |
NZ (1) | NZ212403A (de) |
OA (1) | OA08039A (de) |
PT (1) | PT80684B (de) |
SE (1) | SE464305B (de) |
SU (1) | SU1537136A3 (de) |
YU (2) | YU45725B (de) |
ZA (1) | ZA854710B (de) |
ZW (1) | ZW10385A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991018882A1 (en) * | 1990-05-29 | 1991-12-12 | Nippon Soda Co., Ltd. | N-substituted heterocyclic amidine derivative |
EP4196793A1 (de) | 2020-08-11 | 2023-06-21 | Université de Strasbourg | Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657237A (en) * | 1968-05-22 | 1972-04-18 | Frosst & Co Charles E | Process for making 1 2 5-thiadiazoles in the sinister configuration |
DK160611C (da) * | 1979-09-04 | 1991-09-16 | Bristol Myers Squibb Co | Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider |
EP0040696B1 (de) * | 1980-04-30 | 1986-08-27 | Merck & Co. Inc. | Aminothiadiazole als gastrische Inhibitoren |
US4394508A (en) * | 1980-06-07 | 1983-07-19 | Bristol-Myers Company | Chemical compounds |
DE3168031D1 (en) * | 1980-07-30 | 1985-02-14 | Ici Plc | Guanidine derivatives |
EP0060730A3 (de) * | 1981-03-18 | 1982-12-08 | Imperial Chemical Industries Plc | Bicyclische Derivate |
EP0065823A1 (de) * | 1981-05-13 | 1982-12-01 | Imperial Chemical Industries Plc | Heterozyklische Guanidinderivate als Histamin-H-2-Antagonisten |
FR2542741B1 (fr) * | 1982-03-29 | 1989-12-08 | Bristol Myers Co | 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine |
US4588826A (en) * | 1982-03-29 | 1986-05-13 | Bristol-Myers Company | Ethanediimidamide intermediates |
US4528377A (en) * | 1982-03-29 | 1985-07-09 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
US4517366A (en) * | 1982-03-29 | 1985-05-14 | Bristol-Myers Company | Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles |
US4528378A (en) * | 1982-03-29 | 1985-07-09 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
US4528375A (en) * | 1982-03-29 | 1985-07-09 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
FI832519L (fi) * | 1982-07-12 | 1984-01-13 | Bristol Myers Co | Farmaceutiska foerfaranden och sammansaettningar |
US4520025A (en) * | 1982-07-21 | 1985-05-28 | William H. Rorer, Inc. | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses |
JPS5978171A (ja) * | 1982-10-26 | 1984-05-04 | Ikeda Mohandou:Kk | 複素環式化合物 |
US4440933A (en) * | 1983-03-16 | 1984-04-03 | Bristol-Myers Company | Process for preparing 1,2,5-thiadiazoles |
-
1984
- 1984-06-22 US US06/623,588 patent/US4644006A/en not_active Expired - Fee Related
-
1985
- 1985-06-05 SU SU853906050A patent/SU1537136A3/ru active
- 1985-06-07 CA CA000483419A patent/CA1267412A/en not_active Expired - Lifetime
- 1985-06-07 FR FR8508668A patent/FR2566406B1/fr not_active Expired
- 1985-06-12 CS CS854247A patent/CS257276B2/cs unknown
- 1985-06-13 NZ NZ212403A patent/NZ212403A/xx unknown
- 1985-06-17 FI FI852405A patent/FI852405L/fi not_active Application Discontinuation
- 1985-06-19 AR AR300752A patent/AR240935A1/es active
- 1985-06-19 IL IL75567A patent/IL75567A0/xx not_active IP Right Cessation
- 1985-06-19 NL NL8501766A patent/NL8501766A/nl not_active Application Discontinuation
- 1985-06-19 DD DD85277533A patent/DD240889A5/de not_active IP Right Cessation
- 1985-06-20 GR GR851514A patent/GR851514B/el unknown
- 1985-06-20 SE SE8503110A patent/SE464305B/sv not_active IP Right Cessation
- 1985-06-20 KR KR1019850004457A patent/KR900004321B1/ko not_active IP Right Cessation
- 1985-06-20 IT IT21217/85A patent/IT1190372B/it active
- 1985-06-20 DE DE19853522101 patent/DE3522101A1/de not_active Withdrawn
- 1985-06-21 ZA ZA854710A patent/ZA854710B/xx unknown
- 1985-06-21 PT PT80684A patent/PT80684B/pt not_active IP Right Cessation
- 1985-06-21 DK DK282885A patent/DK282885A/da unknown
- 1985-06-21 HU HU852443A patent/HU193992B/hu not_active IP Right Cessation
- 1985-06-21 AU AU43920/85A patent/AU580605B2/en not_active Ceased
- 1985-06-21 ES ES544409A patent/ES8702902A1/es not_active Expired
- 1985-06-21 NO NO852519A patent/NO161856C/no unknown
- 1985-06-21 IE IE501/89A patent/IE57937B1/en not_active IP Right Cessation
- 1985-06-21 CH CH2657/85A patent/CH665210A5/de not_active IP Right Cessation
- 1985-06-21 GB GB08515749A patent/GB2161157B/en not_active Expired
- 1985-06-21 AT AT0185885A patent/AT390790B/de not_active IP Right Cessation
- 1985-06-21 IE IE155785A patent/IE58261B1/en not_active IP Right Cessation
- 1985-06-21 JP JP60135861A patent/JPS6118775A/ja active Pending
- 1985-06-21 LU LU85969A patent/LU85969A1/fr unknown
- 1985-06-21 ZW ZW103/85A patent/ZW10385A1/xx unknown
- 1985-06-21 BE BE0/215242A patent/BE902724A/fr not_active IP Right Cessation
- 1985-06-24 YU YU105185A patent/YU45725B/sh unknown
- 1985-08-18 OA OA58614A patent/OA08039A/xx unknown
- 1985-10-04 JP JP60221721A patent/JPS61186369A/ja active Pending
-
1986
- 1986-01-31 ES ES551506A patent/ES8702881A1/es not_active Expired
-
1987
- 1987-06-03 YU YU102587A patent/YU45822B/sh unknown
- 1987-07-09 GB GB08716149A patent/GB2192884B/en not_active Expired
-
1989
- 1989-02-08 AU AU29775/89A patent/AU614331B2/en not_active Ceased
- 1989-05-12 CA CA000599622A patent/CA1297875C/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59000326D1 (de) | Verfahren zur herstellung von 3-amino-5-aminocarbonyl-1,2,4-triazol-derivaten. | |
DE3675687D1 (de) | Verfahren zur herstellung von 2,2,6,6,-tetraalkyl-4-piperidylamine. | |
AT386414B (de) | Verfahren zur herstellung des neuen 2'-acetylery- thromycinstearates | |
DE3667167D1 (de) | Verfahren zur herstellung von 1,5-diazido-3-nitrazapentan. | |
DE3677272D1 (de) | Verfahren zur herstellung von 2,2,6,6-tetraalkyl-4-piperidylaminen. | |
DE3676215D1 (de) | Verfahren zur herstellung von 2,3,4,5-tetrafluorbenzoesaeure. | |
DE3680454D1 (de) | Verfahren zur herstellung von halogenhaltigen (2,2)-paracyclophanen. | |
DE3860671D1 (de) | Verfahren zur herstellung von 2,6-dialkylnaphthalin. | |
DE3674055D1 (de) | Verfahren zur herstellung von 1,3,5-triazintrionen. | |
DE3861825D1 (de) | Verfahren zur herstellung von (2,2)-paracyclophan. | |
DE3673049D1 (de) | Verfahren zur herstellung von 1,3-dialkyl-2-imidazolidinon. | |
DE3581884D1 (de) | Verfahren zur herstellung von 2,2'-methylen-bis-(4-hydrocarbyl-6-benzotriazolyl(phenolen). | |
DE3765956D1 (de) | Verfahren zur herstellung von 1-methyl-3,5,7-triaza-1-azoniatricyclodecan-halogeniden. | |
DE58901165D1 (de) | Verfahren zur herstellung von 2,4-dihydroxybenzoesaeure. | |
AT373892B (de) | Verfahren zur herstellung des neuen kristallinen 1,1-dioxopenicillanoyloxymethyl-6-(d-alpha-amin | |
DE3669148D1 (de) | Verfahren zur herstellung von 4,4'-dinitrodibenzylen. | |
AT387776B (de) | Verfahren zur herstellung von neuem 8alphapivaloylamino-9,10-didehydro-ergolin | |
ATA185885A (de) | Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols | |
DE3671436D1 (de) | Verfahren zur herstellung von 2,2,-dibrom-3-oxonitrilen. | |
AT380881B (de) | Verfahren zur herstellung des neuen 3-(4-phenyl-1-piperazinio-1-yl)-1,2-propandiol-(theophyllin-7-yl)-1-propansulfonats | |
AT374203B (de) | Verfahren zur herstellung von neuen 2'-desoxy-3', 5'-di-o-alkylcarbonyl-5-fluoruridinderivaten | |
AT380233B (de) | Verfahren zur herstellung von neuen 1,7,7 | |
AT371442B (de) | Verfahren zur herstellung des neuen 1-(2-chlorbenzyl)-1,2,3,6-tetrahydropyridins | |
AT388730B (de) | Verfahren zur herstellung von neuen azabicyclo (3,3,1) - nonan- derivaten | |
DE3574585D1 (de) | Verfahren zur herstellung von 3,5-dialkyl-4-hydroxybenzoesaeure. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee | ||
REN | Ceased due to non-payment of the annual fee |